HUE047789T2 - RGD peptidek és (bakterio)klorofill fényérzékenyítõk konjugátumai, valamint ezek alkalmazásai - Google Patents

RGD peptidek és (bakterio)klorofill fényérzékenyítõk konjugátumai, valamint ezek alkalmazásai

Info

Publication number
HUE047789T2
HUE047789T2 HUE07805515A HUE07805515A HUE047789T2 HU E047789 T2 HUE047789 T2 HU E047789T2 HU E07805515 A HUE07805515 A HU E07805515A HU E07805515 A HUE07805515 A HU E07805515A HU E047789 T2 HUE047789 T2 HU E047789T2
Authority
HU
Hungary
Prior art keywords
bacterio
photosensitizers
chlorophyll
conjugates
applications
Prior art date
Application number
HUE07805515A
Other languages
English (en)
Hungarian (hu)
Inventor
Avigdor Scherz
Yoram Salomon
Efrat Rubinstein
Alexander Brandis
Doron Eren
Karin Neimann
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of HUE047789T2 publication Critical patent/HUE047789T2/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/12—Cyclic peptides with only normal peptide bonds in the ring
    • C07K5/123—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C07K5/0817—Tripeptides with the first amino acid being basic the first amino acid being Arg
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/12—Cyclic peptides with only normal peptide bonds in the ring
    • C07K5/126—Tetrapeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HUE07805515A 2006-08-23 2007-08-23 RGD peptidek és (bakterio)klorofill fényérzékenyítõk konjugátumai, valamint ezek alkalmazásai HUE047789T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83940906P 2006-08-23 2006-08-23

Publications (1)

Publication Number Publication Date
HUE047789T2 true HUE047789T2 (hu) 2020-05-28

Family

ID=38896083

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE07805515A HUE047789T2 (hu) 2006-08-23 2007-08-23 RGD peptidek és (bakterio)klorofill fényérzékenyítõk konjugátumai, valamint ezek alkalmazásai

Country Status (12)

Country Link
US (1) US20080138278A1 (cg-RX-API-DMAC7.html)
EP (1) EP2061512B1 (cg-RX-API-DMAC7.html)
JP (3) JP2010502574A (cg-RX-API-DMAC7.html)
AU (1) AU2007287205B8 (cg-RX-API-DMAC7.html)
CA (1) CA2661319C (cg-RX-API-DMAC7.html)
DK (1) DK2061512T3 (cg-RX-API-DMAC7.html)
ES (1) ES2763237T3 (cg-RX-API-DMAC7.html)
HU (1) HUE047789T2 (cg-RX-API-DMAC7.html)
IL (1) IL197195A (cg-RX-API-DMAC7.html)
PT (1) PT2061512T (cg-RX-API-DMAC7.html)
RU (1) RU2450018C2 (cg-RX-API-DMAC7.html)
WO (1) WO2008023378A1 (cg-RX-API-DMAC7.html)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6850788B2 (en) 2002-03-25 2005-02-01 Masimo Corporation Physiological measurement communications adapter
US8840549B2 (en) 2006-09-22 2014-09-23 Masimo Corporation Modular patient monitor
US9161696B2 (en) 2006-09-22 2015-10-20 Masimo Corporation Modular patient monitor
US20110223102A1 (en) * 2007-09-14 2011-09-15 Health Research, Inc. Multimodality agents for tumor imaging and therapy
PT2257309T (pt) * 2008-02-27 2020-01-22 Yeda Res And Development Company Ltd Conjugados rgd-(bacterio)clorofila para utilização no diagnóstico de tumores compreendendo domínios necróticos
LT5567B (lt) 2008-08-06 2009-04-27 Vilniaus Universitetas Maisto ir su maistu susietų paviršių nukenksminimo būdas
AU2009305893B2 (en) * 2008-10-23 2014-03-27 Steba Biotech S.A. RGD-containing peptidomimetics and uses thereof
US8263133B2 (en) * 2009-02-18 2012-09-11 The Regents Of The University Of California Multivalent clustering targeting strategy for drug carriers
US9153112B1 (en) 2009-12-21 2015-10-06 Masimo Corporation Modular patient monitor
PL219569B1 (pl) 2010-02-19 2015-05-29 Peptaderm Spółka Z Ograniczoną Odpowiedzialnością Cykliczne tetrapeptydy i ich zastosowanie
WO2012166792A1 (en) 2011-05-31 2012-12-06 North Carolina State University Bacteriochlorin imides
ES2856698T3 (es) * 2011-08-23 2021-09-28 Yeda Res & Dev Fotosensibilizadores de (bacterio)clorofila para el tratamiento de enfermedades y trastornos oculares
EP2766834B1 (en) 2011-10-13 2022-04-20 Masimo Corporation Medical monitoring hub
US9943269B2 (en) 2011-10-13 2018-04-17 Masimo Corporation System for displaying medical monitoring data
US10307111B2 (en) 2012-02-09 2019-06-04 Masimo Corporation Patient position detection system
US10149616B2 (en) 2012-02-09 2018-12-11 Masimo Corporation Wireless patient monitoring device
KR101385196B1 (ko) 2012-05-17 2014-04-14 주식회사 유니크메디케어 광 조사를 이용한 광감각제―펩타이드를 유효성분으로 포함하는 발모 개선 또는 촉진용 조성물 및 이를 이용한 방법
TWI568747B (zh) * 2012-09-05 2017-02-01 上海晟順生物科技有限公司 同時具溶血栓、清除自由基和血栓靶向功能的新穎化合物及其製備方法和用途
US9749232B2 (en) 2012-09-20 2017-08-29 Masimo Corporation Intelligent medical network edge router
RU2548675C9 (ru) * 2013-05-29 2015-11-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Московский государственный университет тонких химических технологий имени М.В. Ломоносова" (МИТХТ им. М.В. Ломоносова) Аминоамиды в ряду бактериохлорофилла a, обладающие фотодинамической активностью, и способ их получения
JP6263716B2 (ja) * 2013-07-31 2018-01-24 国立大学法人 筑波大学 悪性腫瘍のpet診断用トレーサー
US10832818B2 (en) 2013-10-11 2020-11-10 Masimo Corporation Alarm notification system
US9522925B2 (en) * 2014-11-09 2016-12-20 Hong Kong Baptist University Selective cancer tracking eradicator and the uses thereof
TN2017000554A1 (en) * 2015-07-29 2019-04-12 Novartis Ag Novel combination for use in the treatment of cancer
SG10201506686WA (en) * 2015-08-24 2017-03-30 Agency Science Tech & Res Conjugates
EP3344123B1 (en) 2015-08-31 2022-10-26 Masimo Corporation Wireless patient monitoring methods
CN105837666A (zh) * 2015-12-30 2016-08-10 田梗 一种用于诊断糖尿病性视网膜病的蛋白质
SG11201808849TA (en) 2016-04-10 2018-11-29 Yeda Res & Dev Combinational therapies for treatment of cancer comprising a bacteriochlorophyll derivative
US10617302B2 (en) 2016-07-07 2020-04-14 Masimo Corporation Wearable pulse oximeter and respiration monitor
CN107759804B (zh) * 2016-08-19 2019-12-03 四川大学 可定点结合含组氨酸标签蛋白的明胶衍生材料及其制备方法
US11076777B2 (en) 2016-10-13 2021-08-03 Masimo Corporation Systems and methods for monitoring orientation to reduce pressure ulcer formation
US10933134B2 (en) 2017-03-16 2021-03-02 Memorial Sloan Kettering Cancer Center Combination therapies for treatment of cancer
EP3782165A1 (en) 2018-04-19 2021-02-24 Masimo Corporation Mobile patient alarm display
US12495968B2 (en) 2018-10-12 2025-12-16 Masimo Corporation System for transmission of sensor data using dual communication protocol
USD957648S1 (en) 2018-10-12 2022-07-12 Masimo Corporation Dongle
USD1013179S1 (en) 2018-10-12 2024-01-30 Masimo Corporation Sensor device
JP7422751B2 (ja) 2018-10-12 2024-01-26 マシモ・コーポレイション 患者モニターシステム
CN110215438B (zh) * 2019-07-15 2021-06-29 中国医学科学院生物医学工程研究所 双载蒽环类药物及光敏剂介孔硅纳米粒的制备方法与应用
WO2021188999A2 (en) 2020-03-20 2021-09-23 Masimo Corporation Health monitoring system for limiting the spread of an infection in an organization
USD980091S1 (en) 2020-07-27 2023-03-07 Masimo Corporation Wearable temperature measurement device
USD974193S1 (en) 2020-07-27 2023-01-03 Masimo Corporation Wearable temperature measurement device
USD1072837S1 (en) 2020-10-27 2025-04-29 Masimo Corporation Display screen or portion thereof with graphical user interface
CN118510440A (zh) 2021-09-22 2024-08-16 迈心诺公司 用于无创体温测量的可穿戴设备
USD1000975S1 (en) 2021-09-22 2023-10-10 Masimo Corporation Wearable temperature measurement device
CN115960160B (zh) * 2021-10-12 2024-07-16 南京大学 活细胞膜整合素αvβ3聚糖的原位糖链延长方法
EP4432919A1 (en) 2022-01-05 2024-09-25 Masimo Corporation Wrist and finger worn pulse oximetry system
USD1048908S1 (en) 2022-10-04 2024-10-29 Masimo Corporation Wearable sensor
CN117045787B (zh) * 2023-09-27 2025-09-02 中国人民解放军陆军军医大学第二附属医院 一种自组装型纳米光敏剂及制备方法和应用
JPWO2025105486A1 (cg-RX-API-DMAC7.html) * 2023-11-17 2025-05-22

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07503944A (ja) * 1991-11-22 1995-04-27 イエダ リサーチ アンド デベロツプメント カンパニー リミテツド Arg−gly−asp配列の非ペプチド代替物およびそれらからなる医薬組成物
IL102645A (en) * 1992-07-26 1998-02-22 Yeda Res & Dev Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them
IL116126A0 (en) * 1995-11-24 1996-01-31 Yeda Res & Dev Process for the preparation of bacteriochlorophyllis some novel compounds of this type and pharmaceutical compositions comprising them
US20030004334A1 (en) * 2001-06-01 2003-01-02 Ceramoptec Industries, Inc. Water-soluble porphyrin derivatives and methods of their preparation

Also Published As

Publication number Publication date
AU2007287205B8 (en) 2013-08-15
JP2013231039A (ja) 2013-11-14
DK2061512T3 (da) 2020-01-20
AU2007287205B2 (en) 2013-04-18
JP2017039700A (ja) 2017-02-23
CA2661319C (en) 2015-12-01
US20080138278A1 (en) 2008-06-12
PT2061512T (pt) 2020-01-14
RU2009110226A (ru) 2010-09-27
WO2008023378A9 (en) 2008-04-10
IL197195A (en) 2015-10-29
EP2061512A1 (en) 2009-05-27
JP2010502574A (ja) 2010-01-28
EP2061512B1 (en) 2019-10-02
WO2008023378A1 (en) 2008-02-28
ES2763237T3 (es) 2020-05-27
CA2661319A1 (en) 2008-02-28
RU2450018C2 (ru) 2012-05-10
AU2007287205A1 (en) 2008-02-28
IL197195A0 (en) 2009-12-24
JP6177013B2 (ja) 2017-08-09

Similar Documents

Publication Publication Date Title
PT2061512T (pt) Conjugados de péptidos com rgd e fotossensibilizantes de (bacterio)clorofila e as suas utilizações
PL2279210T3 (pl) Lizosomalne peptydy kierujące i ich zastosowania
HUE045046T2 (hu) Aminooxi-csoportot tartalmazó oligoszacharidok és azok konjugátumai
EP2023941A4 (en) PROTEIN NETWORK, NETWORKING METHOD AND ITS APPLICATIONS
HUS1900046I1 (hu) Triazinonokat és vasat tartalmazó készítmények
IL244858A (en) Molecular conjugates of fumarate and a fatty acid, pharmaceutical compositions comprising the same and uses thereof
DK2479174T3 (da) 6-aminoquinazolin- eller 3-cyanquinolinderivater, fremstillingsfremgangsmåder og farmaceutiske anvendelser deraf
BRPI0918122A2 (pt) molécula de diaboy, diaboy, e mólecula dart
EP2136746A4 (en) INDEPENDENT SURGICAL CENTER
AP2009004913A0 (en) 4-phenyl-pyrane-3,5-diones, 4-phenyl-thiopyrane-3,5-diones and cyclohexanetriones as novel herbicides
LT3795573T (lt) Tam tikri triazolopirazinai, jų sudėtis ir jų panaudojimo būdai
BRPI1010881A2 (pt) derivados de triazina e suas aplicações terapêuticas.
DK2245032T3 (da) Folater, sammensætninger og anvendelser deraf
NO20075628L (no) Farmasøytiske formuleringer
IL205705A (en) Anti-influenza antibodies, compositions comprising the same and uses thereof
BRPI1010882A2 (pt) derivados de triazina e suas aplicações terapêuticas.
BRPI0906962A2 (pt) Composto, e, composição farmacêutica
BRPI0716455A2 (pt) Desenvolvimento de componentes de vacina do vírus da dengue
BRPI0822221A2 (pt) Composições aquosas e estáveis de ciclosporina
LTPA2019017I1 (lt) Oftalmologinės kompozicijos ir jų panaudojimas
BRPI0807078A2 (pt) Composto, e, formulação farmacêutica
DE602008002443D1 (de) Drahtloses Stromversorgungssystem, gekapseltes Endoskop und gekapseltes endoskopisches System
BRPI0917681A2 (pt) Composto, e, composição farmacêutica
BR112012003800A2 (pt) composição, peptídeo, e formulação farmacêutica.
EP2052757A4 (en) MEDICAL CAPSULE